GERMANY HEALTHTECH PITCH DECK AGENCY
HealthTech Pitch Deck Design Agency Germany That Turns DiGA Approval Into Investor Capital
Germany's Digital Health Market Rewards Regulatory Precision
Germany is the only country where a digital health application can be prescribed by a physician and automatically reimbursed by national statutory insurance without hospital procurement or individual payer negotiation. GKV covers roughly 90 percent of Germany's 84 million people, meaning one BfArM approval unlocks prescription access to 73 million insured patients, closely tracked by Heartbeat Capital, Flying Health, and Heal Capital.
A German HealthTech raise must satisfy three frameworks simultaneously. BfArM evaluates DiGA applications on patient benefit evidence from randomized trials or structural improvement data. GKV insurers evaluate on chronic disease cost reduction, wanting proof of fewer hospitalizations, emergency visits, or medication adherence failures. Hospital procurement committees evaluating KHZG purchases assess integration with EHR systems such as SAP IS-H, ORBIS, or Nexus, gematik TI connectivity, and BSI cybersecurity compliance. A deck must satisfy all three without contradicting any one.
Slidey is the HealthTech pitch deck design agency Germany founders trust to structure decks meeting BfArM patient benefit standards, GKV cost reduction evidence, and KHZG hospital integration compatibility within one coherent investor narrative.
.png)
Germany Created a Prescription Model the World Has Not Replicated
BfArM's Fast Track grants Tier 1 listing in roughly three months without completed trial data, giving immediate GKV reimbursement while a one-year evidence study runs. Our digital health pitch deck consultants Germany team positions Tier 1 as a revenue milestone, with pricing self-set at €100 to €600 before GKV-Spitzenverband negotiates Tier 2 terms.
TI connects 150,000 physicians, 1,900 hospitals, and 18,000 pharmacies through eGK cards, KIM messaging, and BSI-certified connectors. Certification takes 12 to 24 months, creating a barrier competitors cannot quickly replicate, and Slidey positions it as a distribution infrastructure slide.
German Healthtech Operates In Three Markets That Each Have Different Rules
Our HealthTech pitch deck design service Germany team shows exactly which Fördertatbestände categories your product qualifies for, since KHZG's €4.3 billion fund covers up to 70 percent of eligible hospital costs.
TK, AOK, and Barmer evaluate hospitalization reduction, medication adherence, and Krankengeld savings, alongside DSGVO compliance and DMP interoperability, which Slidey translates into GKV economic terms.
.png)
German Digital Health Investors Think in Patient Pathways
Heartbeat Capital, Flying Health, Heal Capital, and Boehringer Ingelheim Venture Fund evaluate German HealthTech through a statutory patient pathway framework rather than the pure growth metrics US or AU investors apply. German digital health VCs ask which specific GKV disease management programme the product integrates with, which ICD-10 diagnosis code justifies the DiGA prescription, what the patient dropout rate looks like at 30, 60, and 90 days since reimbursement ties to active use, and whether G-BA has issued a positive supplementary benefit assessment. Our HealthTech pitch deck experts in Germany team addresses these four pathway questions before commercial metrics, because German investors form confidence at the regulatory level first. Results below are actual raises.
How German HealthTech Decks Get Structured to Win
German HealthTech Discovery
We map DiGA status, TI integration level, KHZG eligibility, and GKV partnerships.
DiGA Evidence Architecture Slide
We frame BfArM clinical, data, security, and usability evidence as investor milestones.
GKV Prescription Economics Model
We model pricing, prevalence, and retention against comparable DiGA prescription data.
KBV Physician Network Go-to-Market
We map prescriber reach through 150,000 physicians across regional KV associations.
KHZG Hospital Procurement Architecture
We show Fördertatbestände eligibility, co-funding percentage, and comparable hospital references.
Triple Stakeholder Delivery Package
We prepare the VC deck, GKV presentation, and KHZG hospital document together.
German HealthTech Pricing Should Be as Clear as DiGA
Built for early-stage German HealthTech with a DiGA application in preparation or recent Tier 1 listing, raising seed rounds from Heartbeat Capital, Flying Health, or Heal Capital.
$800
German HealthTech Founders Enter Here Whatever Your Stage
German HealthTech Decks That Unlocked GKV Prescription and Investment Capital
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)

.avif)

.avif)
.avif)
Our Pitch Deck Design Portfolio
frequently asked questions
As a HealthTech pitch deck design agency Germany founders trust, we know DiGAV's category 1 patient-relevant outcomes need RCT evidence while category 2 structural improvements need observational data. We also know gematik's connector certification process and which KHZG Fördertatbestände, 2, 4, 5, and 7, most commonly apply to HealthTech companies.
Mental health is Germany's most active DiGA category. Established DiGAs like Deprexis and Velibra show 50,000 to 200,000 annual prescriptions are achievable. Our digital health pitch deck consultants in Germany team builds comparable prescription volume analyses using PHQ-9 and GAD-7 evidence standards into your market opportunity section.
A pilot with TK, AOK, or Barmer sends three signals. As your HealthTech investor deck agency Germany partner, we present the clinical due diligence endorsement, the distribution reach to millions of insured members, and the pricing precedent it sets for later GKV-Spitzenverband negotiation, all within one evidence section.
KHZG committed roughly 1,900 hospitals to government co-funded digitization, creating defined procurement urgency rather than open-ended sales. Our HealthTech pitch deck design service Germany team shows both the active procurement window, where 70 percent co-funding reduces cost objection, and the post-2026 adjacent market opportunity built on that infrastructure.
Yes, both can run in parallel. Our HealthTech pitch deck experts in Germany team designs one coordinated clinical study, meeting BfArM's positive care effect standard for DiGA and the notified body's evidence standard for CE marking under EU MDR Rule 11, shortening the path to reimbursement and market access together.
A standard investor deck takes 7 to 10 business days. The full triple-stakeholder package, including GKV and KHZG documents, takes 14 to 20 days. We regularly work against Heartbeat Capital's biannual committees, BfArM Fast Track deadlines, state Krankenhausgesellschaft submission windows, and the annual conhIT and Medica Digital Health World Congress.
Yes, both. We write DiGA evidence architecture content, gematik TI moat narrative, GKV prescription economics using BfArM prevalence data, KBV go-to-market copy, KHZG co-funding calculations, and GKV cost reduction evidence, alongside full visual design across the triple-stakeholder package. Most founders choose the complete written and designed service.
.avif)
.avif)
.avif)
.avif)





.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)

.avif)
.avif)


.avif)
.png)
.png)




.avif)

.avif)





